How It Works

Covered Conditions

Self-funded employers face skyrocketing prescription benefit costs driven almost exclusively by specialty drug claims. While catastrophic claims in excess of $1M remain rare, specialty medications now account for 80% of total pharmacy spend captured through the medical plan, a factor that is built into traditional stop-loss insurance underwriting models and passed along in the form of higher premiums.

RxPharmacy Assurance’s supplemental stop-loss insurance covers most of the specialty prescription therapies that are used to treat virtually all specialty chronic conditions including:

RX-Pharmacy-Covered Conditions-Specialty Prescriptions - RxPharmacy | Access Affordable Supplemental Stop-Loss Insurance

Leptin deficiency

Hypophosphatasia

Hereditary Angioedema

Hemophilia

Parkinson’s Disease

Cystic Fibrosis

Reimagine
Pharmacy Risk

RxPharmacy Assurance can help self-funded clients remain self-funded and aligned with their goals for choosing to self-fund in the first place: controlling healthcare costs while protecting the health and safety of their members.

Request a quote today, or schedule a consultation to learn more about offering the stability and security of RxPharmacy Assurance to your clients.

463 Mountain View Drive
Suite 301
Colchester, Vermont 05446

Name(Required)

Title

Email(Required)

Phone

Please select an option below that best describes your inquiry(Required)

I’m interested in stop-loss insurance for my client

I want to learn more about the certification process

I have a PR / media inquiry

Other

About RxPharmacy Assurance

RxPharmacy Assurance, Inc. is a Vermont domiciled Sponsored Captive managed by Marsh Captive Management. Upon meeting membership eligibility requirements, self-funded plans of all sizes can access affordable supplemental stop-loss insurance designed specifically to manage pharmacy risk within RxPharmacy Assurance. The unique solution limits the amount that a plan or its stop-loss carrier are required to pay to safeguard against unexpected and potentially catastrophic specialty claims.

Contact

The Challenge